March 30, 2014 8:53 AM | 1 min read |
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Analysts at Jefferies on Friday, March 28, 2014, released its new price target regarding Amgen (NASDAQ: AMGN). Equity analyst Eun K. Yang at Jefferies led the research and raised their price target from $138.00 to $145.00 per share. From the 48 cardiologists' surveys taken, Jeffries is increasing its United States and European Union sales estimates for 2017-2020 by 22 to 49 percent. According to Jeffries, this new estimate reflects its broad use in hypercholesterolemia. Jeffries now estimates sales to be at approximately $1.7 billon in 2019, this is up $0.5 billion from its estimate of $1.2 billion.The price target issued by Jeffries is based on:• 1 P/E multiple of ~16x (2015 P/E for big pharma) to our 2015 EPS forecast of $9.26, discounting at 10 percent. • 2 sum-of-the parts NPV analysis. Risks associated with Amgen include pricing pressure, competition, and regulatory delays/failure of evolocumab (AMG-145)Shares of Amgen are currently trading at $120.55 as of Friday, March 28, 2014.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.